Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-05-16

AUTHORS

Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, Akihiro Ohbora, Takao Kojima, Michiaki Fukui

ABSTRACT

PurposeRecent studies identified that metabolically abnormal non-obese phenotype is a risk factor for cardiovascular diseases. However, little is known about risk factor for progression from metabolically healthy non-overweight to metabolically abnormal phenotype. We hypothesized that fatty liver had a clinical impact on progression from metabolically healthy non-overweight to metabolically abnormal phenotype.MethodsIn this retrospective cohort study, 14,093 Japanese (7557 men and 6736 women), who received the health-checkup program from 2004 to 2012, were enrolled. Overweight and obesity were defined as body mass index 23.0–25.0 and ≥25.0 kg/m2. Four metabolic factors (impaired fasting glucose, hypertension, hypertriglyceridemia and low high density lipoprotein-cholesterol concentration) were used for definition of metabolically healthy (less than two factors) or metabolically abnormal (two or more). We divided the participants into three groups: metabolically healthy non-overweight (9755 individuals, men/women = 4290/5465), metabolically healthy overweight (2547 individuals, 1800/747) and metabolically healthy obesity (1791 individuals, 1267/524). Fatty liver was diagnosed by ultrasonography.ResultsOver the median follow-up period of 5.3 years, 873 metabolically healthy non-overweight, 512 metabolically healthy overweight and 536 metabolically healthy obesity individuals progressed to metabolically abnormal. The adjusted hazard risks of fatty liver on progression were 1.49 (95% confidence interval 1.20–1.83, p = 0.005) in metabolically healthy non-overweight, 1.37 (1.12–1.66, p = 0.002) in metabolically healthy overweight and 1.38 (1.15–1.66, p < 0.001) in metabolically healthy obesity, after adjusting for age, sex, alcohol, smoking, exercise, impaired fasting glucose, hypertension, hypertriglyceridemia, low high density lipoprotein-cholesterol concentration, and abdominal obesity.ConclusionsFatty liver is an independent risk factor for progression from metabolically healthy status to metabolically abnormal phenotype, even in non-overweight individuals. More... »

PAGES

89-97

References to SciGraph publications

  • 2015-08-14. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity in INTERNATIONAL JOURNAL OF OBESITY
  • 2012-11-28. Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome in ACTA DIABETOLOGICA
  • 2015-04-12. Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study in ENDOCRINE
  • 2007-05-17. Light to Moderate Alcohol Consumption Is Associated With Lower Frequency of Hypertransaminasemia in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2015-09-07. Association of body composition and eating behavior in the normal weight obese syndrome in EATING AND WEIGHT DISORDERS - STUDIES ON ANOREXIA, BULIMIA AND OBESITY
  • 2015-04-14. Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: the atherosclerosis risk in communities study in INTERNATIONAL JOURNAL OF OBESITY
  • 2007-09-25. The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2015-04-29. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype in INTERNATIONAL JOURNAL OF OBESITY
  • 2014-10-02. Association of physical activity with lower type 2 diabetes incidence is weaker among individuals at high genetic risk in DIABETOLOGIA
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s12020-017-1313-6

    DOI

    http://dx.doi.org/10.1007/s12020-017-1313-6

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1085413215

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/28508194


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Body Mass Index", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Progression", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fatty Liver", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lipids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Metabolic Syndrome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Obesity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Overweight", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risk Factors", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.272458.e", 
              "name": [
                "Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hashimoto", 
            "givenName": "Yoshitaka", 
            "id": "sg:person.01350130006.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350130006.64"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Diabetology, Kameoka Municipal Hospital, 1-1 Noda, Shinochoshino, Kameoka-city, 621-8585, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Diabetology, Kameoka Municipal Hospital, 1-1 Noda, Shinochoshino, Kameoka-city, 621-8585, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hamaguchi", 
            "givenName": "Masahide", 
            "id": "sg:person.01013261701.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013261701.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.272458.e", 
              "name": [
                "Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fukuda", 
            "givenName": "Takuya", 
            "id": "sg:person.0750162736.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750162736.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan", 
              "id": "http://www.grid.ac/institutes/grid.411456.3", 
              "name": [
                "Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ohbora", 
            "givenName": "Akihiro", 
            "id": "sg:person.0622707067.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622707067.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan", 
              "id": "http://www.grid.ac/institutes/grid.411456.3", 
              "name": [
                "Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kojima", 
            "givenName": "Takao", 
            "id": "sg:person.01300177767.89", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300177767.89"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.272458.e", 
              "name": [
                "Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fukui", 
            "givenName": "Michiaki", 
            "id": "sg:person.016357516722.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016357516722.38"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/ijo.2015.151", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022850586", 
              "https://doi.org/10.1038/ijo.2015.151"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ijo.2015.56", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032538955", 
              "https://doi.org/10.1038/ijo.2015.56"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1111/j.1572-0241.2007.01526.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033520475", 
              "https://doi.org/10.1111/j.1572-0241.2007.01526.x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12020-015-0587-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019179250", 
              "https://doi.org/10.1007/s12020-015-0587-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s40519-015-0215-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047921692", 
              "https://doi.org/10.1007/s40519-015-0215-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ijo.2015.75", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035093068", 
              "https://doi.org/10.1038/ijo.2015.75"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1111/j.1572-0241.2007.01274.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005800354", 
              "https://doi.org/10.1111/j.1572-0241.2007.01274.x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00592-012-0445-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015392427", 
              "https://doi.org/10.1007/s00592-012-0445-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00125-014-3380-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016049042", 
              "https://doi.org/10.1007/s00125-014-3380-z"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2017-05-16", 
        "datePublishedReg": "2017-05-16", 
        "description": "PurposeRecent studies identified that metabolically abnormal non-obese phenotype is a risk factor for cardiovascular diseases. However, little is known about risk factor for progression from metabolically healthy non-overweight to metabolically abnormal phenotype. We hypothesized that fatty liver had a clinical impact on progression from metabolically healthy non-overweight to metabolically abnormal phenotype.MethodsIn this retrospective cohort study, 14,093 Japanese (7557 men and 6736 women), who received the health-checkup program from 2004 to 2012, were enrolled. Overweight and obesity were defined as body mass index 23.0\u201325.0 and \u226525.0\u2009kg/m2. Four metabolic factors (impaired fasting glucose, hypertension, hypertriglyceridemia and low high density lipoprotein-cholesterol concentration) were used for definition of metabolically healthy (less than two factors) or metabolically abnormal (two or more). We divided the participants into three groups: metabolically healthy non-overweight (9755 individuals, men/women\u2009=\u20094290/5465), metabolically healthy overweight (2547 individuals, 1800/747) and metabolically healthy obesity (1791 individuals, 1267/524). Fatty liver was diagnosed by ultrasonography.ResultsOver the median follow-up period of 5.3\u2009years, 873 metabolically healthy non-overweight, 512 metabolically healthy overweight and 536 metabolically healthy obesity individuals progressed to metabolically abnormal. The adjusted hazard risks of fatty liver on progression were 1.49 (95% confidence interval 1.20\u20131.83, p\u2009=\u20090.005) in metabolically healthy non-overweight, 1.37 (1.12\u20131.66, p\u2009=\u20090.002) in metabolically healthy overweight and 1.38 (1.15\u20131.66, p\u2009<\u20090.001) in metabolically healthy obesity, after adjusting for age, sex, alcohol, smoking, exercise, impaired fasting glucose, hypertension, hypertriglyceridemia, low high density lipoprotein-cholesterol concentration, and abdominal obesity.ConclusionsFatty liver is an independent risk factor for progression from metabolically healthy status to metabolically abnormal phenotype, even in non-overweight individuals.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s12020-017-1313-6", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1112251", 
            "issn": [
              "1355-008X", 
              "1559-0100"
            ], 
            "name": "Endocrine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "57"
          }
        ], 
        "keywords": [
          "non-overweight individuals", 
          "fatty liver", 
          "risk factors", 
          "healthy overweight", 
          "healthy obesity", 
          "lower high-density lipoprotein cholesterol concentrations", 
          "high-density lipoprotein cholesterol concentrations", 
          "body mass index (BMI) 23.0", 
          "density lipoprotein cholesterol concentrations", 
          "non-obese phenotypes", 
          "adjusted hazard risk", 
          "retrospective cohort study", 
          "health checkup program", 
          "independent risk factor", 
          "lipoprotein cholesterol concentrations", 
          "median follow", 
          "abdominal obesity", 
          "cohort study", 
          "obesity individuals", 
          "abnormal phenotype", 
          "PurposeRecent studies", 
          "cardiovascular disease", 
          "clinical impact", 
          "metabolic factors", 
          "overweight", 
          "obesity", 
          "liver", 
          "progression", 
          "healthy status", 
          "phenotype", 
          "individuals", 
          "hypertension", 
          "hypertriglyceridemia", 
          "factors", 
          "smoking", 
          "ultrasonography", 
          "ResultsOver", 
          "follow", 
          "disease", 
          "MethodsIn", 
          "age", 
          "sex", 
          "risk", 
          "exercise", 
          "study", 
          "glucose", 
          "status", 
          "participants", 
          "hazard risk", 
          "group", 
          "years", 
          "period", 
          "alcohol", 
          "m2", 
          "concentration", 
          "program", 
          "impact", 
          "definition"
        ], 
        "name": "Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals", 
        "pagination": "89-97", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1085413215"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s12020-017-1313-6"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "28508194"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s12020-017-1313-6", 
          "https://app.dimensions.ai/details/publication/pub.1085413215"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-08-04T17:05", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_722.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s12020-017-1313-6"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12020-017-1313-6'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12020-017-1313-6'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12020-017-1313-6'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12020-017-1313-6'


     

    This table displays all metadata directly associated to this object as RDF triples.

    256 TRIPLES      21 PREDICATES      107 URIs      90 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s12020-017-1313-6 schema:about N006884c874d54976bfac226703ab78cc
    2 N2fe26a3dd43b4196bd7d60c2cc75f721
    3 N424902ec459644f791ece0eb9201d75e
    4 N46d29a15f79848f1b152f34578588107
    5 N57a42c2ef2af4c9aab82f3f85d4f8f11
    6 N5b367c67a41448eb8f7a716b0386389a
    7 N5f2005ed95c64d539e4401cbeea9810f
    8 N630934de8e284f0e8f729f843f9963d1
    9 N633a56d494fb4d5fb72562efd215361b
    10 N8571c7fca5e94499bd1439811f426e98
    11 N87450bedbdc74749923985d2716c9529
    12 N8de3ee975ebb47c09340c8dadac916fb
    13 Nba6aeb0821944a9785618417e8df763e
    14 Nd950cc8848014f328661591533e456b2
    15 Ne35dd6486a9f4f8eafc986ae1f68a911
    16 anzsrc-for:11
    17 anzsrc-for:1117
    18 schema:author N2e5033ff04bf4042b101f9d653d52a86
    19 schema:citation sg:pub.10.1007/s00125-014-3380-z
    20 sg:pub.10.1007/s00592-012-0445-7
    21 sg:pub.10.1007/s12020-015-0587-9
    22 sg:pub.10.1007/s40519-015-0215-y
    23 sg:pub.10.1038/ijo.2015.151
    24 sg:pub.10.1038/ijo.2015.56
    25 sg:pub.10.1038/ijo.2015.75
    26 sg:pub.10.1111/j.1572-0241.2007.01274.x
    27 sg:pub.10.1111/j.1572-0241.2007.01526.x
    28 schema:datePublished 2017-05-16
    29 schema:datePublishedReg 2017-05-16
    30 schema:description PurposeRecent studies identified that metabolically abnormal non-obese phenotype is a risk factor for cardiovascular diseases. However, little is known about risk factor for progression from metabolically healthy non-overweight to metabolically abnormal phenotype. We hypothesized that fatty liver had a clinical impact on progression from metabolically healthy non-overweight to metabolically abnormal phenotype.MethodsIn this retrospective cohort study, 14,093 Japanese (7557 men and 6736 women), who received the health-checkup program from 2004 to 2012, were enrolled. Overweight and obesity were defined as body mass index 23.0–25.0 and ≥25.0 kg/m2. Four metabolic factors (impaired fasting glucose, hypertension, hypertriglyceridemia and low high density lipoprotein-cholesterol concentration) were used for definition of metabolically healthy (less than two factors) or metabolically abnormal (two or more). We divided the participants into three groups: metabolically healthy non-overweight (9755 individuals, men/women = 4290/5465), metabolically healthy overweight (2547 individuals, 1800/747) and metabolically healthy obesity (1791 individuals, 1267/524). Fatty liver was diagnosed by ultrasonography.ResultsOver the median follow-up period of 5.3 years, 873 metabolically healthy non-overweight, 512 metabolically healthy overweight and 536 metabolically healthy obesity individuals progressed to metabolically abnormal. The adjusted hazard risks of fatty liver on progression were 1.49 (95% confidence interval 1.20–1.83, p = 0.005) in metabolically healthy non-overweight, 1.37 (1.12–1.66, p = 0.002) in metabolically healthy overweight and 1.38 (1.15–1.66, p < 0.001) in metabolically healthy obesity, after adjusting for age, sex, alcohol, smoking, exercise, impaired fasting glucose, hypertension, hypertriglyceridemia, low high density lipoprotein-cholesterol concentration, and abdominal obesity.ConclusionsFatty liver is an independent risk factor for progression from metabolically healthy status to metabolically abnormal phenotype, even in non-overweight individuals.
    31 schema:genre article
    32 schema:isAccessibleForFree false
    33 schema:isPartOf N85b9c076c65a44b889eb796d11d457bd
    34 Nc83541f733ad4677be1625cc500d38f0
    35 sg:journal.1112251
    36 schema:keywords MethodsIn
    37 PurposeRecent studies
    38 ResultsOver
    39 abdominal obesity
    40 abnormal phenotype
    41 adjusted hazard risk
    42 age
    43 alcohol
    44 body mass index (BMI) 23.0
    45 cardiovascular disease
    46 clinical impact
    47 cohort study
    48 concentration
    49 definition
    50 density lipoprotein cholesterol concentrations
    51 disease
    52 exercise
    53 factors
    54 fatty liver
    55 follow
    56 glucose
    57 group
    58 hazard risk
    59 health checkup program
    60 healthy obesity
    61 healthy overweight
    62 healthy status
    63 high-density lipoprotein cholesterol concentrations
    64 hypertension
    65 hypertriglyceridemia
    66 impact
    67 independent risk factor
    68 individuals
    69 lipoprotein cholesterol concentrations
    70 liver
    71 lower high-density lipoprotein cholesterol concentrations
    72 m2
    73 median follow
    74 metabolic factors
    75 non-obese phenotypes
    76 non-overweight individuals
    77 obesity
    78 obesity individuals
    79 overweight
    80 participants
    81 period
    82 phenotype
    83 program
    84 progression
    85 retrospective cohort study
    86 risk
    87 risk factors
    88 sex
    89 smoking
    90 status
    91 study
    92 ultrasonography
    93 years
    94 schema:name Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals
    95 schema:pagination 89-97
    96 schema:productId N29871b76f72246cdbb98113774b88522
    97 N4b8e65db7e334789902cc5993032c23e
    98 Nea948c52fa6e4f92952d207c975e27e4
    99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085413215
    100 https://doi.org/10.1007/s12020-017-1313-6
    101 schema:sdDatePublished 2022-08-04T17:05
    102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    103 schema:sdPublisher N466e872c50a04b949f6622a543c40487
    104 schema:url https://doi.org/10.1007/s12020-017-1313-6
    105 sgo:license sg:explorer/license/
    106 sgo:sdDataset articles
    107 rdf:type schema:ScholarlyArticle
    108 N006884c874d54976bfac226703ab78cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Fatty Liver
    110 rdf:type schema:DefinedTerm
    111 N1b256adfd5c3460f98504ab939b13076 rdf:first sg:person.0750162736.53
    112 rdf:rest N38cf91b429dd454ab029de8713270b2b
    113 N29871b76f72246cdbb98113774b88522 schema:name doi
    114 schema:value 10.1007/s12020-017-1313-6
    115 rdf:type schema:PropertyValue
    116 N2e5033ff04bf4042b101f9d653d52a86 rdf:first sg:person.01350130006.64
    117 rdf:rest Ndd9c277fb8a744159f3ab0b9bdfa2168
    118 N2fe26a3dd43b4196bd7d60c2cc75f721 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Lipids
    120 rdf:type schema:DefinedTerm
    121 N38cf91b429dd454ab029de8713270b2b rdf:first sg:person.0622707067.31
    122 rdf:rest N6fc2b074d27c440f92844340451d59c7
    123 N424902ec459644f791ece0eb9201d75e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Male
    125 rdf:type schema:DefinedTerm
    126 N466e872c50a04b949f6622a543c40487 schema:name Springer Nature - SN SciGraph project
    127 rdf:type schema:Organization
    128 N46d29a15f79848f1b152f34578588107 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Risk Factors
    130 rdf:type schema:DefinedTerm
    131 N4b8e65db7e334789902cc5993032c23e schema:name dimensions_id
    132 schema:value pub.1085413215
    133 rdf:type schema:PropertyValue
    134 N57a42c2ef2af4c9aab82f3f85d4f8f11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Overweight
    136 rdf:type schema:DefinedTerm
    137 N5b367c67a41448eb8f7a716b0386389a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Adult
    139 rdf:type schema:DefinedTerm
    140 N5f2005ed95c64d539e4401cbeea9810f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Body Mass Index
    142 rdf:type schema:DefinedTerm
    143 N630934de8e284f0e8f729f843f9963d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Female
    145 rdf:type schema:DefinedTerm
    146 N633a56d494fb4d5fb72562efd215361b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Insulin
    148 rdf:type schema:DefinedTerm
    149 N6fc2b074d27c440f92844340451d59c7 rdf:first sg:person.01300177767.89
    150 rdf:rest Nbc72a29c42e64bee83b05b55706ba112
    151 N8571c7fca5e94499bd1439811f426e98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Humans
    153 rdf:type schema:DefinedTerm
    154 N85b9c076c65a44b889eb796d11d457bd schema:volumeNumber 57
    155 rdf:type schema:PublicationVolume
    156 N87450bedbdc74749923985d2716c9529 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Retrospective Studies
    158 rdf:type schema:DefinedTerm
    159 N8de3ee975ebb47c09340c8dadac916fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Disease Progression
    161 rdf:type schema:DefinedTerm
    162 Nba6aeb0821944a9785618417e8df763e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Obesity
    164 rdf:type schema:DefinedTerm
    165 Nbc72a29c42e64bee83b05b55706ba112 rdf:first sg:person.016357516722.38
    166 rdf:rest rdf:nil
    167 Nc83541f733ad4677be1625cc500d38f0 schema:issueNumber 1
    168 rdf:type schema:PublicationIssue
    169 Nd950cc8848014f328661591533e456b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Middle Aged
    171 rdf:type schema:DefinedTerm
    172 Ndd9c277fb8a744159f3ab0b9bdfa2168 rdf:first sg:person.01013261701.08
    173 rdf:rest N1b256adfd5c3460f98504ab939b13076
    174 Ne35dd6486a9f4f8eafc986ae1f68a911 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Metabolic Syndrome
    176 rdf:type schema:DefinedTerm
    177 Nea948c52fa6e4f92952d207c975e27e4 schema:name pubmed_id
    178 schema:value 28508194
    179 rdf:type schema:PropertyValue
    180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    181 schema:name Medical and Health Sciences
    182 rdf:type schema:DefinedTerm
    183 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    184 schema:name Public Health and Health Services
    185 rdf:type schema:DefinedTerm
    186 sg:journal.1112251 schema:issn 1355-008X
    187 1559-0100
    188 schema:name Endocrine
    189 schema:publisher Springer Nature
    190 rdf:type schema:Periodical
    191 sg:person.01013261701.08 schema:affiliation grid-institutes:None
    192 schema:familyName Hamaguchi
    193 schema:givenName Masahide
    194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013261701.08
    195 rdf:type schema:Person
    196 sg:person.01300177767.89 schema:affiliation grid-institutes:grid.411456.3
    197 schema:familyName Kojima
    198 schema:givenName Takao
    199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300177767.89
    200 rdf:type schema:Person
    201 sg:person.01350130006.64 schema:affiliation grid-institutes:grid.272458.e
    202 schema:familyName Hashimoto
    203 schema:givenName Yoshitaka
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350130006.64
    205 rdf:type schema:Person
    206 sg:person.016357516722.38 schema:affiliation grid-institutes:grid.272458.e
    207 schema:familyName Fukui
    208 schema:givenName Michiaki
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016357516722.38
    210 rdf:type schema:Person
    211 sg:person.0622707067.31 schema:affiliation grid-institutes:grid.411456.3
    212 schema:familyName Ohbora
    213 schema:givenName Akihiro
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622707067.31
    215 rdf:type schema:Person
    216 sg:person.0750162736.53 schema:affiliation grid-institutes:grid.272458.e
    217 schema:familyName Fukuda
    218 schema:givenName Takuya
    219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750162736.53
    220 rdf:type schema:Person
    221 sg:pub.10.1007/s00125-014-3380-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1016049042
    222 https://doi.org/10.1007/s00125-014-3380-z
    223 rdf:type schema:CreativeWork
    224 sg:pub.10.1007/s00592-012-0445-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015392427
    225 https://doi.org/10.1007/s00592-012-0445-7
    226 rdf:type schema:CreativeWork
    227 sg:pub.10.1007/s12020-015-0587-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019179250
    228 https://doi.org/10.1007/s12020-015-0587-9
    229 rdf:type schema:CreativeWork
    230 sg:pub.10.1007/s40519-015-0215-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1047921692
    231 https://doi.org/10.1007/s40519-015-0215-y
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1038/ijo.2015.151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022850586
    234 https://doi.org/10.1038/ijo.2015.151
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1038/ijo.2015.56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032538955
    237 https://doi.org/10.1038/ijo.2015.56
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.1038/ijo.2015.75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035093068
    240 https://doi.org/10.1038/ijo.2015.75
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.1111/j.1572-0241.2007.01274.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005800354
    243 https://doi.org/10.1111/j.1572-0241.2007.01274.x
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.1111/j.1572-0241.2007.01526.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033520475
    246 https://doi.org/10.1111/j.1572-0241.2007.01526.x
    247 rdf:type schema:CreativeWork
    248 grid-institutes:None schema:alternateName Department of Diabetology, Kameoka Municipal Hospital, 1-1 Noda, Shinochoshino, Kameoka-city, 621-8585, Kyoto, Japan
    249 schema:name Department of Diabetology, Kameoka Municipal Hospital, 1-1 Noda, Shinochoshino, Kameoka-city, 621-8585, Kyoto, Japan
    250 rdf:type schema:Organization
    251 grid-institutes:grid.272458.e schema:alternateName Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan
    252 schema:name Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan
    253 rdf:type schema:Organization
    254 grid-institutes:grid.411456.3 schema:alternateName Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan
    255 schema:name Department of Gastroenterology, Murakami Memorial Hospital, Asahi University, Gifu, Japan
    256 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...